NPI: 1164976437 · FORT DODGE, IA 50501 · Clinical Medical Laboratory · NPI assigned 08/04/2016
Authorized official WILLIAMS, DAVID controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, DAVID (PRESIDENT/CEO) |
| Parent Organization | IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION |
| NPI Enumeration Date | 08/04/2016 |
Other providers sharing the same authorized official: WILLIAMS, DAVID
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,486 | $224K |
| 2019 | 19,348 | $179K |
| 2020 | 14,339 | $128K |
| 2021 | 14,740 | $189K |
| 2022 | 12,000 | $108K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80050 | General health panel | 2,148 | 1,975 | $95K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 113 | 109 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,402 | 6,040 | $44K |
| 80053 | Comprehensive metabolic panel | 4,713 | 4,468 | $43K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 94 | 83 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,864 | 2,697 | $39K |
| 87660 | 1,854 | 1,742 | $37K | |
| 87480 | 1,854 | 1,741 | $36K | |
| 87510 | 1,853 | 1,741 | $36K | |
| 80061 | Lipid panel | 3,213 | 3,081 | $36K |
| 87507 | 73 | 67 | $28K | |
| 36415 | Collection of venous blood by venipuncture | 11,183 | 10,050 | $27K |
| 86703 | 2,221 | 1,859 | $24K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,214 | 2,735 | $22K |
| 87653 | 659 | 611 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,555 | 2,472 | $20K |
| 84702 | 1,645 | 1,065 | $19K | |
| 84439 | 2,229 | 2,109 | $17K | |
| 84703 | 2,233 | 2,140 | $17K | |
| 87070 | 1,700 | 1,598 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,142 | 2,002 | $15K |
| 86762 | 1,278 | 992 | $13K | |
| 86850 | 1,779 | 1,424 | $11K | |
| 87186 | 1,222 | 1,112 | $10K | |
| 85027 | 1,670 | 1,610 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 102 | 98 | $8K |
| 87088 | 932 | 848 | $7K | |
| 83550 | 856 | 814 | $6K | |
| 80069 | 878 | 832 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 183 | 179 | $6K |
| 86140 | 1,182 | 1,127 | $6K | |
| 82728 | 487 | 460 | $5K | |
| 83540 | 914 | 865 | $5K | |
| 82947 | 1,657 | 1,328 | $5K | |
| 81001 | 1,636 | 1,481 | $4K | |
| 82950 | 978 | 892 | $4K | |
| 87081 | 542 | 526 | $4K | |
| 86900 | 1,654 | 1,309 | $4K | |
| 86901 | 1,650 | 1,305 | $3K | |
| 85018 | 1,517 | 1,486 | $3K | |
| 87581 | 94 | 83 | $3K | |
| 87486 | 94 | 83 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 93 | 83 | $3K |
| 82043 | 708 | 688 | $3K | |
| 82570 | 756 | 727 | $3K | |
| 85014 | 1,183 | 1,159 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 15 | 15 | $2K |
| 87205 | 473 | 434 | $2K | |
| 87077 | 162 | 148 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13 | 13 | $1K |
| 83735 | 196 | 187 | $1K | |
| 85652 | 420 | 404 | $1K | |
| 84153 | 57 | 55 | $911.05 | |
| 83690 | 116 | 109 | $739.37 | |
| 80076 | 87 | 79 | $604.07 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15 | 12 | $447.44 |
| 83880 | 15 | 12 | $415.56 | |
| 85610 | 167 | 121 | $326.39 | |
| 84460 | 75 | 70 | $322.57 | |
| 82150 | 28 | 27 | $169.32 | |
| 82247 | 39 | 24 | $166.69 | |
| 82565 | 15 | 15 | $44.51 | |
| 3044F | 13 | 13 | $0.00 |